Whalegun
Home

Regeneron Pharmaceuticals REGN spent $610K on lobbying in Q4 2025 · Taxation, Health Issues and 3 more issues

Trade details

Type
Lobbying report
Amount
$610,000
Quarter
Q4 2025
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
26/01/20

Up 7.0% from last quarter

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN spent $610K on lobbying in Q4 2025 · Taxation, Health Issues and 3 more issues | Whalegun